- Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial2011 | Faculty of Medicine in Hradec Králové
- Rituximab and its indications2019 | Publication without faculty affiliation
- Rituximab in Membranous Nephropathy2021 | First Faculty of Medicine
- Rituximab in the treatment of rheumatic diseases.2008 | First Faculty of Medicine
- Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma2016 | Faculty of Medicine in Hradec Králové
- Maintenance treatment with rituximab in nonhodgkin's lymphoma2012 | Faculty of Medicine in Hradec Králové
- Rituximab in the chronic glomerulonephritis2010 | First Faculty of Medicine
- Rituximab in hands of a nephrologist - first experience2009 | First Faculty of Medicine
- Rituximab in the treatment of patients with glomerular disease2011 | First Faculty of Medicine
- Anti-CD20 (rituximab) treatment for atopic eczema2008 | Second Faculty of Medicine
- Rituximab – new biological drug for rheumatoid arthritis treatment.2008 | First Faculty of Medicine
- Patient with follicular lymphoma and subcutaneous administration of rituximab2014 | Faculty of Medicine in Hradec Králové
- Subcutaneous administration of rituximab in B-non-Hodgkin's lymphoma patients2014 | Publication without faculty affiliation
- Maintenance therapy with rituximab for non-Hodgkin's lymphoma - opportunities in 20102010 | Faculty of Medicine in Hradec Králové
- Role of rituximab in the treatment of pemphigus vulgaris2023 | First Faculty of Medicine
- Rituximab infusion-related toxicity in patients with chronic lymphocytic leukemia2015 | Faculty of Medicine in Hradec Králové
- Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial2011 | Faculty of Medicine in Hradec Králové
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis2010 | First Faculty of Medicine
- Rituximab in the Treatment of Pemphigus Vulgaris - Case Report2020 | First Faculty of Medicine
- Efficiency of rituximab in ANCA-associated vasulitis in comparison with standard induction and maintanance treatment2013 | First Faculty of Medicine
- Maintenance therapy with rituximab in patients with follicular lymphoma after 1 line treatment - PRIMA study2011 | Faculty of Medicine in Hradec Králové
- Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis2016 | First Faculty of Medicine
- Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma2023 | First Faculty of Medicine
- Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Rituximab for treatment of severe renal disease in ANCA associated vasculitis2016 | First Faculty of Medicine
- Rituximab is more effective than cyclophosphamide in the treatment of relapsing ANCA-associated vasculitis.Commentary on:NEJM 363-2010,221-2322010 | First Faculty of Medicine
- Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)2020 | Faculty of Medicine in Hradec Králové
- The efficacy of rituximab in consolidation treatment after chemotherapy CHOP in patients with follicular lymphoma2005 | First Faculty of Medicine
- Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study2019 | Faculty of Medicine in Hradec Králové
- Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?2015 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine